For health care professionals
Fred Hutchinson Cancer Center unites comprehensive care and advanced research to provide the latest cancer treatment options and accelerate discoveries that prevent, treat and defeat cancer and infectious diseases worldwide. Fred Hutch is a nationally-recognized treatment center that provides a variety of resources for community physicians and other health care professionals.
Fred Hutch is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
Oncology Insights blog
This blog is designed for Fred Hutch referring providers who bring world-class cancer care to their patients. Gain timely insights from our nationally-renowned experts through our e-newsletter. We are privileged to partner with you.
The latest updates in cancer research and clinical care are now available in an on-demand format. The recent 13th Annual Comprehensive Hematology and Oncology Review Course features leading scientists from Fred Hutchinson Cancer Center and the University of Washington School of Medicine. Starting Dec. 1, 2022, you can access part or all of this course on demand and earn CME credits.
New developments in the complex and rapidly changing world of acute myeloid leukemia (AML) promise to improve health outcomes for people with the disease. They include: advances in diagnostics, development of new therapeutic agents, revised risk stratification criteria from European Leukemia Net (ELN), and updated classification guidelines from the World Health Organization (WHO).
Fred Hutchinson Cancer Center medical oncologist Christina Baik, MD, MPH, recently shared the latest research on metastatic NSCLC and her treatment approach at the 13th Annual Comprehensive Hematology and Oncology Review Course. Fred Hutch was created by the merger of the Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center.
Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and determining whether and when to use HIPEC — requires an experienced, coordinated team of specialists.
We strive to support Fred Hutch’s vision to improve cancer care by providing the highest-quality medical resources and education to our community.
Fred Hutch provides symposiums, webinars and other educational programs about specific disease programs focusing on advancements to diagnostic techniques and treatment modalities. Our programs feature physician speakers from Fred Hutch and UW Medicine.
Visiting physician program
A visiting physician is a medical doctor with recent patient primary care experience who rotates through the clinical services of the Blood and Marrow Transplantation (BMT) units.
If you have questions about specific treatments or processes, and would like to set up a meeting to discuss with one of our physicians, the outreach team would be happy to help. Please send us an email at email@example.com
Subscribe to our e-newsletter